NEW YORK – Autoimmune disease diagnostic firm Exagen announced on Sunday a 10 to 13 percent year over year increase in its preliminary fourth quarter revenues.
NEW YORK – Autoimmune disease diagnostic firm Exagen announced on Sunday a 10 to 13 percent year over year increase in its preliminary fourth quarter revenues.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.